| Literature DB >> 32590617 |
Timothy D Malouff1, Sunil Krishnan1, Christopher L Hallemeier2, Michael G Haddock2, Bradford S Hoppe1, Chris Beltran2, Anita Mahajan2, Daniel M Trifiletti.
Abstract
Pancreatic cancer is the fourth most common cause of cancer-related morality worldwide, and the prognosis remains poor despite aggressive therapy. Carbon ion radiotherapy has favorable radiobiological and physical characteristics in the treatment, including a higher linear energy transfer and higher relative biological effectiveness, which increase the cell kill while potentially reducing toxicities to nearby normal tissues. Although small, early clinical studies have shown promise in both the resectable and unresectable settings to improve local control and overall survival while minimizing toxicities. Currently, there are several trials, including 2 sponsored by institutions in the United States, investigating the role of carbon ion radiotherapy for the treatment of locally advanced pancreatic cancer.Entities:
Mesh:
Year: 2020 PMID: 32590617 DOI: 10.1097/MPA.0000000000001566
Source DB: PubMed Journal: Pancreas ISSN: 0885-3177 Impact factor: 3.327